PATH
Menu

Contact: Kaitlin Christenson, 202.822.0033, kchristenson@path.org

Global Health Technologies Coalition receives funding to encourage new health solutions for the developing world

Washington, DC, May 15, 2009—A coalition of more than two dozen nonprofit organizations working to accelerate the development and delivery of new health products to prevent HIV/AIDS, tuberculosis, malaria, and neglected tropical diseases has received a three-year grant from the Bill & Melinda Gates Foundation. The Global Health Technologies Coalition works to educate US policymakers about the benefits of new vaccines, microbicides, drugs, and diagnostics to improve health in developing countries.

PATH will serve as secretariat of the coalition, whose members include a wide variety of groups including: Aeras Global TB Vaccine Foundation, AIDS Vaccine Advocacy Coalition, Alliance for Microbicide Development, BIO Ventures for Global Health, Drugs for Neglected Diseases initiative, Elizabeth Glaser Pediatric AIDS Foundation, Global Alliance for TB Drug Development, Global Campaign for Microbicides, Global Network for Neglected Tropical Diseases, Infectious Disease Society of America, Institute for OneWorld Health, International AIDS Vaccine Initiative, PATH Malaria Vaccine Initiative, Medicines for Malaria Venture, Pediatric Dengue Vaccine Initiative, PneumoADIP, Research!America, Results for Development Institute, Henry L. Stimson Center, and Washington Global Health Alliance. Read more about the coalition, and get links to member websites.

The need for health technologies

More than six million people die each year from HIV/AIDS, tuberculosis, and malaria, primarily in developing countries. In addition, one billion people are affected annually by neglected tropical diseases such as leishmaniasis and African sleeping sickness. New vaccines, drugs, microbicides, and diagnostics offer the potential to slow these global threats and save millions of lives each year.

About the Global Health Technologies Coalition

The coalition seeks to engage and inform US policymakers about policies to accelerate the creation of new solutions to longstanding global health problems in low-resource settings through increased and effective use of public resources, incentives to encourage private investment, and improved regulatory systems. Read more about the coalition.